|
English
|
正體中文
|
简体中文
|
總筆數 :2854037
|
|
造訪人次 :
45304773
線上人數 :
1204
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 2232976-2232985 / 2346973 (共234698頁)
<< < 223293 223294 223295 223296 223297 223298 223299 223300 223301 223302 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-08-24T08:01:30Z |
Membranous nephropathy: A review on the pathogenesis, diagnosis, and treatment
|
Lai W.L.; Yeh T.H.; Chen P.M.; CHIEH-KAI CHAN; Chiang W.C.; Chen Y.M.; Wu K.D.; Tsai T.J. |
| 臺大學術典藏 |
2021-08-24T08:21:11Z |
Effects of Proximal Priority and Distal Priority Robotic Priming Techniques With Impairment-Oriented Training of Upper Limb Functions in Patients With Chronic Stroke: Study Protocol For A Single-Blind, Randomized Controlled Trial.
|
Lee, Y-C., Li, Y-C., LIN, K-C*., Chen C-L., Wu, Y-H., Kuo, C-C., Yeh, Y-P., Liu, T-X. |
| 臺大學術典藏 |
2021-08-24T08:23:26Z |
Increasing New Delhi metallo-β-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018
|
YU-SHAN HUANG; Tsai W.-C.; Li J.-J.; Chen P.-Y.; Wang J.-T.; Chen Y.-T.; Chen F.-J.; Lauderdale T.-L.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:26Z |
A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan
|
Pan S.-C.; YU-SHAN HUANG; Hsieh S.-M.; Chen Y.-C.; Chang S.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:26Z |
High rates of misidentification of uncommon Candida species causing bloodstream infections using conventional phenotypic methods
|
YU-SHAN HUANG; Wang F.-D.; Chen Y.-C.; Huang Y.-T.; Hsieh M.-H.; Hii I.-M.; Lee Y.-L.; Ho M.-W.; Liu C.-E.; Chen Y.-H.; Liu W.-L. |
| 臺大學術典藏 |
2021-08-24T08:23:27Z |
Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics
|
Liu W.-D.; Chang S.-Y.; Lan T.-Y.; Lin Y.-C.; Kao J.-H.; Liao C.-H.; Tsai M.-J.; Kuo P.-H.; YU-SHAN HUANG; Wang J.-T.; Sheng W.-H.; Hsieh S.-C.; Chiang B.-L.; Chen Y.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:27Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
YU-SHAN HUANG; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Sun H.-Y.; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Chang S.-Y.; Cheng A.; YU-SHAN HUANG; Huang S.-H.; Huang Y.-C.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Reversal of Viral Latency and Induction of Gag-Specific T-Cell Responses in HIV-1-Infected Adults Through Cyclic Treatment Interruption of Rosuvastatin: A Proof-of-Concept Study
|
Hsieh S.-M.; Pan S.-C.; YU-SHAN HUANG; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; Lin K.-Y.; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; YU-SHAN HUANG; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
Showing items 2232976-2232985 of 2346973 (234698 Page(s) Totally)
<< < 223293 223294 223295 223296 223297 223298 223299 223300 223301 223302 > >>
View [10|25|50] records per page
|
